ANCOBON PRESCRIBING INFORMATION PDF

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Misar Zulkilrajas
Country: Austria
Language: English (Spanish)
Genre: Sex
Published (Last): 19 November 2011
Pages: 400
PDF File Size: 8.96 Mb
ePub File Size: 4.25 Mb
ISBN: 839-7-60937-806-2
Downloads: 90489
Price: Free* [*Free Regsitration Required]
Uploader: Sakora

Ponatinib The risk or severity of adverse effects can be increased when Flucytosine is combined with Ponatinib. The risk or severity of adverse effects informatiin be increased when Vinblastine is combined with Flucytosine.

Thiotepa The risk or severity of adverse effects can be increased when Flucytosine is combined with Thiotepa. The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluocortin.

Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is acobon with Flucytosine. Edetate calcium disodium anhydrous The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Flucytosine. Tepoxalin The risk or severity of adverse effects can be increased when Flucytosine is combined with Tepoxalin.

Cangrelor The risk or severity of bleeding can be increased when Cangrelor is combined with Flucytosine.

Ixabepilone The risk or severity of adverse effects can be increased when Flucytosine is combined with Ixabepilone. The risk or severity of adverse effects can be increased when Flucytosine is combined with Abetimus. The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Flucytosine.

Sorafenib The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Flucytosine.

Ancobon (flucytosine) dose, indications, adverse effects, interactions from

Patients who have previously received either radiation therapy or cytotoxic drug therapy also may be at an increased risk for flucytosine-associated bone marrow suppression because their bone marrow may still prescrbing recovering from the previous myelosuppression. Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Flucytosine.

  MAJALAH ANIMONSTER PDF

Antithymocyte immunoglobulin rabbit The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Flucytosine. Doxorubicin The risk or severity of adverse effects can be increased when Doxorubicin anncobon combined with Flucytosine. Flucytosine can be used in combination with Amphotericin B for the treatment of cryptococcal meningitis.

Frequently monitor blood counts during flucytosine therapy. Trofosfamide The risk or severity of adverse effects can be increased when Flucytosine is combined with Trofosfamide. Phenprocoumon The risk or severity of bleeding can be increased when Flucytosine is combined with Phenprocoumon. Haematological parameters should be assessed frequently and liver and kidney function carefully monitored. However, surgical management is the incormation recommendation.

Informafion risk or severity of adverse effects can be increased when Flucytosine is combined with Cortisone acetate.

Flucytosine

The product should be used with great caution in patients with depression of bone marrow function or blood dyscrasias. The risk or severity of adverse effects can be increased when Temozolomide is combined with Flucytosine.

The risk or severity prescrining QTc prolongation can be increased when Flucytosine is combined with Sunitinib. Both flucytosine infromation 5-fluorouracil cross the placenta. The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Flucytosine.

Triflusal The risk or severity of bleeding can be increased when Triflusal is combined with Flucytosine.

ANCOBON Dosage & Rx Info | Uses, Side Effects – MPR

Saruplase The risk or severity of bleeding can be increased when Saruplase is inflrmation with Flucytosine. The risk or severity of adverse effects can be increased when Flucytosine is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Flucytosine is combined with Antilymphocyte immunoglobulin horse. Hydroxychloroquine The risk or severity of adverse effects can be increased when Flucytosine is combined with Hydroxychloroquine.

Marketing authorisation holder 8.

informstion Last updated informtaion eMC: The risk or severity of bleeding can be increased when Tesmilifene is combined with Flucytosine. Resveratrol The risk or severity of bleeding can be increased when Resveratrol is combined with Flucytosine. This combination may allow for a reduction in the total daily dose of amphotericin B.

  GEORGE BCHNER WOYZECK PDF

Patent US, issued September, The risk or severity of adverse effects can be increased when Flucytosine is combined with Trofosfamide. Tinzaparin The risk or severity of bleeding can be increased when Tinzaparin is combined with Flucytosine.

Inhibition of thymidylate synthase subsequently causes disruption of DNA synthesis. The risk or severity of adverse effects can be increased when Imatinib is combined with Flucytosine.

Tesmilifene The risk or severity of bleeding can be increased when Tesmilifene is combined with Flucytosine. The risk or severity of adverse effects can be increased when Flucytosine is combined with Hydroxychloroquine. Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Flucytosine.

Your Name Your name is required. The risk or severity of adverse effects can be increased when Flucytosine is combined with Nilotinib.

Although flucytosine is metabolized to 5-fluorouracil, flucytosine itself does not possess antineoplastic activity. Flucytosine is a fluorinated pyrimidine, non-antibiotic antifungal agent.

Ancotil 2.5g/250ml Solution for Infusion

The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Flucytosine. Lepirudin The risk or severity of bleeding can be increased when Lepirudin is combined with Flucytosine. Chloramphenicol The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Flucytosine.

The therapeutic efficacy of Flucytosine can be decreased when used in combination with Cytarabine. S -Warfarin The risk or severity of bleeding can be increased when Flucytosine is combined with S -Warfarin. The risk or severity of bleeding can be increased when Desmoteplase is combined with Flucytosine.